|
|
Volumn 103, Issue 9, 2011, Pages 711-713
|
|
Unraveling the prostate genome
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
HYBRID PROTEIN;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN;
PROTEIN CADM2;
PROTEIN MAG12;
SORAFENIB;
TMPRSS2 ETS PROTEIN;
TRASTUZUMAB;
TUMOR SUPPRESSOR PROTEIN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
ONCOPROTEIN;
TMPRSS2 ERG FUSION PROTEIN, HUMAN;
TMPRSS2-ERG FUSION PROTEIN, HUMAN;
BREAST CANCER;
GENE FUSION;
GENE MUTATION;
GENE REARRANGEMENT;
GENE SEQUENCE;
GENOME;
HUMAN;
MALE;
NOTE;
ONCOGENE;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN DNA BINDING;
TUMOR GENE;
DNA SEQUENCE;
GENETICS;
HUMAN GENOME;
METHODOLOGY;
MUTATION;
PROSTATE TUMOR;
ANTINEOPLASTIC AGENTS;
GENOME, HUMAN;
HUMANS;
MALE;
MUTATION;
ONCOGENE PROTEINS, FUSION;
PROSTATIC NEOPLASMS;
SEQUENCE ANALYSIS, DNA;
|
|
EID: 79959574201
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr167 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
